side effect

06/13/2012

NuvaRing Contraceptive Ring Lawsuits & Investigations

NuvaRing Birth Control

NuvaRing is the trade name for a combined hormonal contraceptive vaginal ring manufactured by Merck (formerly Schering-Plough, formerly Organon), that is available by prescription. It is a flexible plastic (ethylene-vinyl acetate copolymer) ring that releases a low dose of a progestinand estrogen over three weeks. It is considered to be a “third-generation” birth control method. Numerous lawsuits have been filed against the manufacturers, distributors, and marketers of the NuvaRing birth control vaginal ring, and recent court cases are now allowing these... Read More
04/20/2012

About Yaz, Yasmin, and Ocella (Drospirenone) Litigation

78431709

Some of the newest birth control pills -- Yaz, Yasmin, and Ocella -- are the subject of over 1,000 lawsuits that claim the medications increase the risk of blood clots and stroke and cause other health problems in women who take them. Litigation focuses on Bayer Healthcare's failure to disclose the risks of taking these fourth generation combination birth control pills. Recent research regarding Yaz and blood clots prompted the FDA to require Bayer to add warnings to the drug... Read More
04/20/2012

Yaz, Yasmin, Beyaz, and Ocella Birth Control Pills

yasmin-box-blister

Yasmin is the brand name for a birth control pill that is generically known as drospirenone.  It is also a treatment for moderate acne and premenstrual dysphoric disorder (PMDD) in women.  It is produced by Bayer Healthcare.  Bayer Healthcare also manufactures “Yaz” birth control pills. The main difference between Yaz and Yasmin is in the level of estrogen contained in each pill compared to the level of progestins. Yasmin has brought Bayer Healthcare $487 million in sales in the US alone with $1.5... Read More
11/21/2011

FDA Pulls Avastin From the Market

On Friday, November 18, 2011 US Food and Drug Administration (FDA) announced that it had pulled from the market the drug Avastin.  Avastin is used for treatment of patients with metastatic breast cancer, however there is no evidence the drug is safe and effective for that use. Researchers said Avastin may increase a cancer patient's risk of having a fatal reaction to treatment when it is added to chemotherapy. Please visit our website www.Audetlaw.com for additional... Read More
10/28/2009

Companies Race To Bring Diet Drugs To Market – NPR Health Blog : NPR

#drugs Companies Race To Bring Diet Drugs To Market - NPR Health Blog : NPR: "In the battle against obesity, doctors and patients are short on weapons.Eating better and exercising more are, of course, the best first choices for shrinking one's waistline. But often they're not enough to get the job done, and stomach-shrinking surgery remains a daunting and costly option.Now, three small drugmakers are looking to boost the odds of success for dieters with a new crop of medicines... Read More
10/28/2009

Antipsychotic Drugs Add To Kids’ Weight – NPR Health Blog : NPR

Antipsychotic Drugs Add To Kids' Weight - NPR Health Blog : NPR: "Antipsychotic drugs used in kids can carry a steep health cost. Many children gain an unhealthy amount of weight after just a few months on the medicines.Research just published in JAMA found the drugs led to weight gains ranging from about 10 to 19 pounds, depending on the medicine, in about 11 weeks. The analysis looked at popular brand-name drugs Abilify, Risperdal, Seroquel and Zyprexa."... Read More
10/28/2009

Reglan and TK

Reglan (metoclopramide) is a drug manufactured by Baxter Healthcare Corporation. It was first approved for use in the U.S. in 1980. It is prescribed for digestive-tract problems such as reflux, delayed stomach emptying and nausea. Although doctors were warned early on that this drug could cause a serious neurological disorder, it took the Food and Drug Administration years to issue a black-box warning about this complication. Read more:... Read More